# Rocket Companies, Inc.: financial statements, quarterly

RKT · NYSE · CIK 1805284 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/rkt.md) · [Financials](/companies/rkt/financials.md) · [Filings](/companies/rkt/filings.md) · [Insiders](/companies/rkt/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/rkt/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [694 d](/filings/0001628280-26-013283.md) | [1,384](/filings/0001805284-25-000065.md) | [1,301](/filings/0001805284-25-000088.md) | [647](/filings/0001805284-25-000136.md) | [1,770 d](/filings/0001628280-26-013283.md) | [1,101](/filings/0001628280-26-033694.md) | [1,451](/filings/0001628280-26-054577.md) | [1,695](/filings/0001628280-26-068434.md) | [2,447 d](/filings/0001628280-26-013283.md) | [2,941](/filings/0001628280-26-033694.md) | [2,784](/filings/0001628280-26-054577.md) | [3,284](/filings/0001628280-26-068434.md) |
| Gross profit | $m | [150 d](/filings/0001805284-25-000010.md) | [709](/filings/0001805284-24-000067.md) | [617](/filings/0001805284-24-000137.md) | [(54.4)](/filings/0001805284-24-000176.md) | [1,042 d](/filings/0001805284-25-000010.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | [109](/filings/0001628280-26-033694.md) | [155](/filings/0001628280-26-054577.md) | [235](/filings/0001628280-26-068434.md) | not reported | [349](/filings/0001628280-26-033694.md) | [374](/filings/0001628280-26-054577.md) | [359](/filings/0001628280-26-068434.md) |
| Income tax | $m | [(10.4) d](/filings/0001628280-26-013283.md) | [7.7](/filings/0001805284-25-000065.md) | [14.1](/filings/0001805284-25-000088.md) | [(15.9)](/filings/0001805284-25-000136.md) | [26.1 d](/filings/0001628280-26-013283.md) | [(11.0)](/filings/0001628280-26-033694.md) | [(10.0)](/filings/0001628280-26-054577.md) | [(61.0)](/filings/0001628280-26-068434.md) | [101 d](/filings/0001628280-26-013283.md) | [103](/filings/0001628280-26-033694.md) | [52.0](/filings/0001628280-26-054577.md) | [249](/filings/0001628280-26-068434.md) |
| Net income | $m | [(11.1) d](/filings/0001628280-26-013283.md) | [16.2](/filings/0001805284-25-000065.md) | [1.3](/filings/0001805284-25-000088.md) | [(22.0)](/filings/0001805284-25-000136.md) | [33.5 d](/filings/0001628280-26-013283.md) | [(10.0)](/filings/0001628280-26-033694.md) | [(2.0)](/filings/0001628280-26-054577.md) | [(124)](/filings/0001628280-26-068434.md) | [68.0 d](/filings/0001628280-26-013283.md) | [297](/filings/0001628280-26-033694.md) | [230](/filings/0001628280-26-054577.md) | [709](/filings/0001628280-26-068434.md) |
| Diluted EPS | $ per share | not reported | [0.11](/filings/0001805284-25-000065.md) | [0.01](/filings/0001805284-25-000088.md) | [(0.19)](/filings/0001805284-25-000136.md) | not reported | [(0.08)](/filings/0001628280-26-033694.md) | [(0.01)](/filings/0001628280-26-054577.md) | [(0.06)](/filings/0001628280-26-068434.md) | not reported | [0.10](/filings/0001628280-26-033694.md) | [0.08](/filings/0001628280-26-054577.md) | [0.25](/filings/0001628280-26-068434.md) |
| Basic EPS | $ per share | not reported | [0.12](/filings/0001805284-25-000065.md) | [0.01](/filings/0001805284-25-000088.md) | [(0.16)](/filings/0001805284-25-000136.md) | not reported | [(0.07)](/filings/0001628280-26-033694.md) | [(0.01)](/filings/0001628280-26-054577.md) | [(0.06)](/filings/0001628280-26-068434.md) | not reported | [0.11](/filings/0001628280-26-033694.md) | [0.08](/filings/0001628280-26-054577.md) | [0.25](/filings/0001628280-26-068434.md) |

- Revenue: us-gaap:RevenuesNetOfInterestExpense
- Gross profit: us-gaap:GrossProfit
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [1.1](/filings/0001628280-26-013283.md) | [0.9](/filings/0001805284-25-000065.md) | [1.3](/filings/0001805284-25-000088.md) | [1.2](/filings/0001805284-25-000136.md) | [1.3](/filings/0001628280-26-013283.md) | [1.4](/filings/0001628280-26-033694.md) | [5.1](/filings/0001628280-26-054577.md) | [5.8](/filings/0001628280-26-068434.md) | [2.7](/filings/0001628280-26-068434.md) | [2.7](/filings/0001628280-26-033694.md) | [3.1](/filings/0001628280-26-054577.md) | [2.7](/filings/0001628280-26-068434.md) |
| Total assets | $bn | [19.2](/filings/0001805284-25-000010.md) | [22.2](/filings/0001805284-24-000067.md) | [23.6](/filings/0001805284-24-000137.md) | [25.1](/filings/0001805284-24-000176.md) | [24.5](/filings/0001628280-26-013283.md) | [25.3](/filings/0001805284-25-000065.md) | [30.4](/filings/0001805284-25-000088.md) | [33.6](/filings/0001805284-25-000136.md) | [60.7](/filings/0001628280-26-068434.md) | [59.4](/filings/0001628280-26-033694.md) | [61.0](/filings/0001628280-26-054577.md) | [60.2](/filings/0001628280-26-068434.md) |
| Total liabilities | $bn | [10.9](/filings/0001805284-25-000010.md) | [13.6](/filings/0001805284-24-000067.md) | [14.8](/filings/0001805284-24-000137.md) | [16.8](/filings/0001805284-24-000176.md) | [15.5](/filings/0001628280-26-013283.md) | [16.7](/filings/0001805284-25-000065.md) | [22.9](/filings/0001805284-25-000088.md) | [24.7](/filings/0001805284-25-000136.md) | [37.8](/filings/0001628280-26-068434.md) | [36.2](/filings/0001628280-26-033694.md) | [37.4](/filings/0001628280-26-054577.md) | [35.8](/filings/0001628280-26-068434.md) |
| Long-term debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [10.4](/filings/0001628280-26-068434.md) | [10.4](/filings/0001628280-26-033694.md) | [10.8](/filings/0001628280-26-054577.md) | [10.7](/filings/0001628280-26-068434.md) |
| Shareholders' equity | $bn | [8.3](/filings/0001628280-26-013283.md) | [8.6](/filings/0001805284-25-000136.md) | [8.8](/filings/0001805284-25-000136.md) | [8.4](/filings/0001805284-25-000136.md) | [9.0](/filings/0001628280-26-068434.md) | [8.6](/filings/0001628280-26-068434.md) | [7.4](/filings/0001628280-26-068434.md) | [8.9](/filings/0001628280-26-068434.md) | [22.9](/filings/0001628280-26-068434.md) | [23.2](/filings/0001628280-26-068434.md) | [23.5](/filings/0001628280-26-068434.md) | [24.3](/filings/0001628280-26-068434.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [1,395 d](/filings/0001628280-26-013283.md) | [(3,013)](/filings/0001805284-25-000065.md) | [(122) d](/filings/0001805284-25-000088.md) | [(1,337) d](/filings/0001805284-25-000136.md) | [1,842 d](/filings/0001628280-26-013283.md) | [(796)](/filings/0001628280-26-033694.md) | [(1,852) d](/filings/0001628280-26-054577.md) | [(49.0) d](/filings/0001628280-26-068434.md) | [(1,230) d](/filings/0001628280-26-013283.md) | [1,857](/filings/0001628280-26-033694.md) | [(1,212) d](/filings/0001628280-26-054577.md) | [1,905 d](/filings/0001628280-26-068434.md) |
| Capital expenditure | $m | [(0.9) d](/filings/0001628280-26-013283.md) | [14.0](/filings/0001805284-25-000065.md) | [16.0 d](/filings/0001805284-25-000088.md) | [18.7 d](/filings/0001805284-25-000136.md) | [19.2 d](/filings/0001628280-26-013283.md) | [14.0](/filings/0001628280-26-033694.md) | [16.0 d](/filings/0001628280-26-054577.md) | [21.0 d](/filings/0001628280-26-068434.md) | [40.0 d](/filings/0001628280-26-013283.md) | [43.0](/filings/0001628280-26-033694.md) | [34.0 d](/filings/0001628280-26-054577.md) | [43.0 d](/filings/0001628280-26-068434.md) |
| Share repurchases | $m | [0.0 d](/filings/0001805284-25-000010.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [1,975](/filings/0001805284-24-000067.md) | [1,979](/filings/0001805284-24-000137.md) | [1,984](/filings/0001805284-24-000176.md) | [1,992](/filings/0001805284-25-000065.md) | [140](/filings/0001805284-25-000088.md) | [2,003](/filings/0001805284-25-000136.md) | [2,002](/filings/0001628280-26-033694.md) | [171](/filings/0001628280-26-054577.md) | [2,106](/filings/0001628280-26-068434.md) | [2,847](/filings/0001628280-26-033694.md) | [2,844](/filings/0001628280-26-054577.md) | [2,845](/filings/0001628280-26-068434.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 31, 2026, 02:57 ET. No prices; not investment advice.